Inflammatory markers and outcomes in cardiovascular disease

PLoS Medicine

Volumn 6, Issue 9, 2009, Pages

  Kritharides, Leonard ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; FIBRINOGEN; INTERLEUKIN 6; PRAVASTATIN;

CARDIOVASCULAR DISEASE; GROUPS BY AGE; HUMAN; LEUKOCYTE COUNT; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SHORT SURVEY; BLOOD; HEART INFARCTION; INFLAMMATION; MORTALITY; NOTE; PROGNOSIS; PROSPECTIVE STUDY; STROKE;

BIOLOGICAL MARKERS; HUMANS; INFLAMMATION; MYOCARDIAL INFARCTION; PROGNOSIS; PROSPECTIVE STUDIES; STROKE;

EID: 70349647341     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1000147     Document Type: Short Survey

References (11)

1. Tedgui A, Mallat Z (2006) Cytokines in atherosclerosis: Pathogenic and regulatory pathways. Physiol Rev 86: 515-581.
2. Ridker PMBJ, Cook NR, Rifai N (2003) C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially healthy American women. Circulation 107: 391-397.
3. Sabatine MS, Morrow DA, Jablonski KA, Rice MM, Warnica JW, et al. (2007) Prognostic significance of the Centers for Disease Control/ American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease. Circulation 115: 1528-1536.
4. Di Napoli M, Schwaninger M, Cappelli R, Ceccarelli E, Di Gianfilippo G, et al. (2005) Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members. Stroke 36: 1316-1329. (Pubitemid 40798763)
5. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, et al. (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350: 1387-1389. (Pubitemid 38419992)
6. Cook NR (2007) Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 115: 928-935. (Pubitemid 46294733)
7. Zethelius B, Berglund L, Sundström J, Ingelsson E, Basu S, et al. (2008) Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 358: 2107-2116. (Pubitemid 351679597)
8. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, et al. (2008) Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359: 2195-2207.
9. Sattar N, Murray H, Welsh P, Blauw GJ, Buckley BM, et al. (2009) Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events? PLoS Med 6(6): e99. doi:10.1371/journal.pmed.1000099.
10. WhiteleyW, JacksonC, Lewis S, Lowe G, Rumley A, et al. (2009) Inflammatory markers and poor outcome after stroke: A prospective cohort study and systematic review of interleukin 6. PLoS Med 6(8): e145. doi:10.1371/journal.pmed.1000145.
11. Audebert HJ, Rott MM, Eck T, Haberl H (2004) Systemic inflammatory response depends on initial stroke severity but is attenuated by successful thrombolysis. Stroke 35: 2128-2133. (Pubitemid 39129573)